SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Phil Cressman who wrote (23404)7/21/1998 5:03:00 PM
From: Machaon  Read Replies (1) | Respond to of 32384
 
MRK was down about $10 today. They didn't miss earnings by much. CNBC was saying that MRK has a great drug pipeline.

So....... what did the market think about drug pipelines? It shat on MRK's pipeline!

This is, indeed, a "show me the money" market (except for Internet stocks). You could issue an IPO named SHAT.COM, and it would be bid up to $1 billion capitalization.

I've been investing in biotech for several years now. I think that I have found out that Biotech investors have been mandated by God to suffer for long periods of time in between rallies! <g>

LGND is still one of my favorite stock holdings. In total they will have 5 possible NDA's within the next 12 months, two already in the FDA's hands.

Good luck, Bob



To: Phil Cressman who wrote (23404)7/25/1998 11:26:00 AM
From: bluejeans  Respond to of 32384
 
LIGAND PHARM CL B 2,431,675 shares short as of July 24,98 report in WSJ interactive. 156 warrants short.